Table 3.

Univariate analysis of the risk of reassessment and re-investigation by neurological diagnosis

	Relative risk (95% CI) and p value
	Reassessment		Re-investigation
Negative likelihood
Headaches and facial pains	0.22 (0.11 to 0.43)	<0.001	0.13 (0.04 to 0.41)	<0.001
Epileptic seizures	0.37 (0.12 to 1.12)	0.052	0.22 (0.03 to 1.57)	0.086
Positive likelihood
Multiple sclerosis and neuroinflammatory disorders	2.18 (1.24 to 3.85)	0.013	3.82 (2.00 to 7.32)	<0.001
Spinal disorders and radiculopathies	2.28 (1.36 to 3.84)	0.004	1.14 (0.38 to 3.47)	0.810
Non-specific neurological symptoms	1.75 (1.04 to 2.96)	0.045	1.99 (0.95 to 4.16)	0.071
Functional neurological disorders	1.41 (0.90 to 2.21)	0.145	1.37 (0.71 to 2.63)	0.353
Neuromuscular and cranial neuropathies	1.45 (0.83 to 2.52)	0.208	1.81 (0.86 to 3.79)	0.123
Vestibular and cerebellar disorder	1.58 (0.66 to 3.76)	0.327	0.71 (0.10 to 4.79)	0.716
Movement disorders	1.27 (0.68 to 2.35)	0.461	1.04 (0.39 to 2.75)	0.941